The University of Washington has officially opened the Center for Medication Development for Substance Use Disorders after raising more than $2 million in funding. Researchers aim to put resources toward developing a vaccine that could cure drug addiction.
“What I’m hoping to achieve is pretty much every year, we’re going to start a new clinical trial,” said Professor Marco Pravetoni, who will be leading the Center for Medication Development for Substance Use Disorders.